SCHEMBL5607559

SCHEMBL5607559

CCOC(=O)C(=Cc1ccc(OCc2ccccc2)cc1)CC

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.77
ALDH1A1 P00352 2/20 0.58
LMNA P02545 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
GSK3B P49841 3/20 0.51
BACE1 P56817 3/20 0.51
KDM4E B2RXH2 2/20 0.51
MAPT P10636 2/20 0.51
NPC1 O15118 1/20 0.51
GAA P10253 1/20 0.51
RAB9A P51151 1/20 0.51
MAOB P27338 2/20 0.49
PTPN1 P18031 1/20 0.48
ALOX5 P09917 1/20 0.48
NR4A1 P22736 1/20 0.48
NR4A2 P43354 1/20 0.48
NR4A3 Q92570 1/20 0.48
PRMT5 O14744 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5607445 0.90 NR1H4 (0.73) NR1H4ALDH1A1LMNAL3MBTL1MEN1
SCHEMBL5607543 0.90 NR1H4 (0.62) NR1H4ALDH1A1LMNAL3MBTL1MEN1
SCHEMBL5608023 0.89 NR1H4 (0.61) NR1H4ALDH1A1LMNAL3MBTL1MEN1
SCHEMBL2804642 0.88 NR1H4 (0.79) NR1H4ALDH1A1LMNAL3MBTL1MEN1
SCHEMBL2804643 0.88 NR1H4 (0.79) NR1H4ALDH1A1LMNAL3MBTL1MEN1
SCHEMBL5607676 0.88 NR1H4 (0.63) NR1H4ALDH1A1MEN1KMT2AGSK3B
SCHEMBL2807676 0.88 NR1H4 (0.79) NR1H4ALDH1A1LMNAL3MBTL1MEN1
SCHEMBL5607741 0.88 NR1H4 (0.70) NR1H4ALDH1A1LMNAL3MBTL1MEN1
SCHEMBL6041621 0.87 NR1H4 (1.00) NR1H4ALDH1A1LMNAL3MBTL1MEN1
SCHEMBL3978528 0.87 NR1H4 (0.64) NR1H4ALDH1A1LMNAL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed
EP-1687250-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS Takasago International Corporation (JP) 2006-08-09 EP disclosed
WO-2005051882-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids ALDH1A2, ALDH1A3, GRHPR NR1H4 220/4885ALDH1A1 5/4885LMNA 1420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.